Loading...

CRDF CARDIFF ONCOLOGY INC Management Changes 8-K Filing

CRDF

CRDF

CARDIFF ONCOLOGY INC

(CRDF)

2026 8-K

Management Changes

Management Changes

Corporate Presentation

Financial Results Update

Leadership Changes

Quarterly Results

Clinical Trial Update

Financial Statements

Financial Results

By-law Amendments

Positive Trial Data

Q2 Financial Results

Earnings Reports

Annual Meeting of Stockholders

Amendment and Stock Options

Earnings Reports

Conference Presentation

Financial Results and Clini...

Regulation FD Disclosure

Financial Results and Certi...

Stock Options Granted

Annual Meeting of Stockholders

Earnings Reports

Regulation FD Disclosure

Earnings Reports

Appointment of Chief Medica...

External Links:

On January 27, 2026, Cardiff Oncology, Inc. announced the departure of CEO Dr. Mark Erlander and CFO James Levine, appointing Dr. Mani Mohindru as interim CEO and promoting Brigitte Lindsay to Chief Accounting Officer. The company also shared positive updates from a clinical trial involving onvansertib for treating metastatic colorectal cancer.

AI Assistant

CARDIFF ONCOLOGY INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.